The Minaris Advanced Therapies Data Breach: Incident Facts and Free Case Review

Minaris Advanced Therapies is a contract development and manufacturing organization specializing in cell and gene therapy, placing it within the highly sensitive healthcare and biotechnology sector. As a provider in this industry, the company typically collects and maintains highly confidential patient and clinical trial participant data, including detailed medical histories, genetic information, and protected health identifiers. In 2025, the company officially reported a data security incident to the Indiana Attorney General, confirming that unauthorized access to their systems occurred. If you received a data breach notification letter from Minaris, it indicates that your personal or health-related information may have been compromised. This notification is intended to inform you of the incident and provide guidance on the steps you should take to protect your identity and medical privacy.

State

Indiana

Breach date

October 1, 2024

Reported

September 10, 2025